Vivos Therapeutics Inc (VVOS)
2.26
+0.02
(+0.89%)
USD |
NASDAQ |
May 21, 14:59
Vivos Therapeutics Gross Profit Margin (Quarterly): 56.65% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 56.65% |
December 31, 2023 | 59.67% |
September 30, 2023 | 57.50% |
June 30, 2023 | 61.80% |
March 31, 2023 | 60.59% |
December 31, 2022 | 60.35% |
September 30, 2022 | 58.78% |
June 30, 2022 | 61.85% |
March 31, 2022 | 70.01% |
December 31, 2021 | 70.71% |
Date | Value |
---|---|
September 30, 2021 | 70.02% |
June 30, 2021 | 80.59% |
March 31, 2021 | 78.02% |
December 31, 2020 | 81.30% |
September 30, 2020 | 78.45% |
June 30, 2020 | 83.34% |
March 31, 2020 | 75.58% |
December 31, 2019 | 71.69% |
September 30, 2019 | 77.34% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
56.65%
Minimum
Mar 2024
83.34%
Maximum
Jun 2020
69.17%
Average
70.02%
Median
Sep 2021
Gross Profit Margin (Quarterly) Benchmarks
Perspective Therapeutics Inc | -- |
Electromed Inc | 74.85% |
Xtant Medical Holdings Inc | 62.07% |
Asensus Surgical Inc | -172.1% |
Senseonics Holdings Inc | 6.64% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -771.5% |
Return on Assets | -122.8% |
Return on Invested Capital | -771.5% |
Profit Margin (Quarterly) | -110.1% |
Operating Margin (Quarterly) | -110.7% |
Return on Net Operating Assets | -187.8% |